MarketWire -- London, UK; Brentwood, TN, US: 8 August 2008 - Protherics PLC
("Protherics" or the "Company"), the international biopharmaceutical
company focused on critical care and cancer, in accordance with Listing
Rule 3.5.6, notifies the following details in respect of a block
listing for the Company's 6% Unsecured Convertible Loan Notes:
